Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis

Author:

Kumar Gunjan1,Jena Samikshya1,Snigdha Niher Tabassum2,Basha Sakeenabi3,Narayanan Jayaraj Kodangattil4ORCID,Luke Alexander Maniangat56ORCID

Affiliation:

1. Department of Public Health Dentistry, Kalinga Institute of Dental Sciences, KIIT Deemed to Be University, Patia, Bhubaneswar 751024, Odisha, India

2. Paediatric Dentistry Unit, School of Dental Sciences, Universiti Sains Malaysia, Health Campus, Kota Bharu 16150, Kelantan, Malaysia

3. Department of Community Dentistry, Faculty of Dentistry, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia

4. Medical and Dental Sciences Department, College of Dentistry, Ajman University, Ajman P.O. Box 346, United Arab Emirates

5. Department of Clinical Science, College of Dentistry, Ajman University, Al-Jurf, Ajman P.O. Box 346, United Arab Emirates

6. Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Al-Jurf, Ajman P.O. Box 346, United Arab Emirates

Abstract

This systematic review and meta-analysis sought to evaluate the acceptability levels for COVID vaccine(s) in various states in India. Published articles in PubMed/Scopus/Cochrane/DOAJ/the Web of Science that focused on assessing COVID-19 vaccine hesitation/vaccine acceptance using a survey/questionnaire were included. After extensive research, 524 records were found, and after screening on the basis of eligibility criteria, only 23 papers were added to this review. Increased vaccine assumption percentage (>70%) among the population was found in two surveys nationwide (92.8%) and in Delhi (79.5%). For pooled estimates of COVID-19 vaccine acceptance and heterogeneity, twenty-three studies (23) consisting of 39,567 individuals reported for acceptance of COVID 19 vaccine in India.. Out of these, 26,028 individuals accepted the COVID-19 vaccine, giving a pooled estimate of 62.6% (95% CI: 55.6–69.4) with considerable heterogeneity (χ2 = 3397.3, p < 0.0001; I2 = 99.40%). The results of this study give a brief insight into the percentage acceptance and hesitancy among the Indian population regarding COVID-19 vaccine immunisation. Future research and vaccine education initiatives can be steered by the findings of this work as a starting point.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference51 articles.

1. (2022, October 12). Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

2. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries;Warren;Nat. Med.,2021

3. (2022, October 24). Available online: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines.

4. A global survey of potential acceptance of a COVID-19 vaccine;Lazarus;Nat. Med.,2021

5. (2022, November 01). Available online: https://www.who.int/health-topics/coronavirus#tab=tab_1.

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3